RECRUITING

Development of an Educational Patient Decision Aid (Treatments in Advanced Cancer - Decision Aid, TA-DA) to Promote Shared Decision Making for Third-line or Beyond Palliative Systemic Therapy

Description

To develop an educational patient decision aid for advanced cancer patients to prepare them to have conversations with their clinicians about treatment options (Treatments in Advanced cancer - Decision Aid, TA-DA).

Conditions

Study Overview

Study Details

Study overview

To develop an educational patient decision aid for advanced cancer patients to prepare them to have conversations with their clinicians about treatment options (Treatments in Advanced cancer - Decision Aid, TA-DA).

Development of an Educational Patient Decision Aid (Treatments in Advanced Cancer - Decision Aid, TA-DA) to Promote Shared Decision Making for Third-line or Beyond Palliative Systemic Therapy

Development of an Educational Patient Decision Aid (Treatments in Advanced Cancer - Decision Aid, TA-DA) to Promote Shared Decision Making for Third-line or Beyond Palliative Systemic Therapy

Condition
Advanced Cancer
Intervention / Treatment

-

Contacts and Locations

Houston

The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States, 77030

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Clinicians (Part I/II/III):
  • 2. Patients (Part I/II/III):
  • * Diagnosis of advanced cancer (i.e., metastatic, relapsed, and/or incurable disease as defined by the treating oncologist) who has received at least 2 lines of palliative systemic therapy\*
  • * Patient-rated ECOG performance status of 2 or greater
  • * Able to make treatment decisions based on the clinical judgement of the oncology team
  • * English speaking
  • * patient has started, is receiving, and/or has completed second-line palliative systemic therapy or beyond
  • 3. Caregivers (Part I/II/III):
  • * Age 18 or older
  • * Currently a primary caregiver to a patient who satisfies the patient eligibility criteria listed above
  • * For the study purposes, a primary caregiver is defined as:
  • * someone who provides physical, emotional, decisional and/or logistical assistance to the patient regularly (e.g. daily, weekly);
  • * can be a family member, friend, or other individual in a close relationship with the patient;
  • * must be identified by the patient and self-identify as the primary person providing caregiving support to the patient
  • * Able to provide informed consent and participate in the study
  • * English speaking
  • * (Part I/II/III): Diagnosis of cognitive impairment or dementia requiring a surrogate decision maker as determined by the clinical team
  • * (Part III only): Participants in Part I and II

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

M.D. Anderson Cancer Center,

David Hui, MD, PRINCIPAL_INVESTIGATOR, M.D. Anderson Cancer Center

Study Record Dates

2030-07-31